Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
May 30, 2026
Chicago, Illinois
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Mariana C. Castells, MD, PhD
Tsewang Tashi, MD
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Benjamin Levy, MD
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Charles E. Geyer Jr., MD, FACP
Komal Jhaveri, MD, FACP
Addressing Unmet Needs in Metastatic Uveal Melanoma
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Chelsea Cole, MD
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
All Sides of the Joint: Integrated TGCT Care Across Specialties
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.